ANIMAL HEALTH NEWS-April

Recent developments in the animal health industry include Royal Canin's dedication to societal initiatives beyond nutrition, Virbac's expansion efforts in Asia and Japan, Elanco's campaign against parvovirus and board appointments, and MSD Animal Health's contributions to the Mission Rabies program. Furthermore, advancements in vaccine distribution, pharmaceutical innovations, and collaborative agreements aimed at enhancing animal health and well-being are underway.

?? ROYAL CANIN?, a global company that offers Health Through Nutrition for cats and dogs, recognizes the importance of creating positive actions for society through initiatives that go beyond nutrition and remains committed to addressing issues that impact the health and well-being of animals. An example of this is its recent partnership with the Veterinary Hospital of the Faculty of Veterinary Medicine and Zootechnics of the University of S?o Paulo (USP), located in Butant?, S?o Paulo/SP. The company made investments at the end of last year to furnish and revitalize the reception area of the Veterinary Hospital, which was adapted to perform Cat Friendly appointments, to better accommodate cats and their owners, separately from dogs. The Veterinary Hospital (HOVET), established in 1981 and considered the largest in Latin America in terms of the number of cases treated, was a pioneer in offering veterinary specialties and surgeries in Brazil, and today serves animals from different regions of the city of S?o Paulo. (marcaesmercados.com.br , Feb).

?? Virbac Asia: Their teams have been working hard to offer training programs in veterinary dermatology to Asian professionals trying to support the growth of canine dermatology in the area, bringing veterinarians an effective routine in their daily practice. ?With ???????????????????? ??????????????, they worked with veterinarians for better long-term management of atopic dermatitis. (corporate.virbac.com , March).

?? Virbac acquired Sasaeah, a leading animal health player in Japan. On April 1, they completed this strategic acquisition to bring Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species. Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. Ltd. and Kyoto Biken Laboratories Inc.) under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which around 50% from vaccines. With strong footholds in Japan, Sasaeah develops, manufactures and markets a large portfolio of veterinary products targeting both farm animals and companion animals. (corporate.virbac.com , April 2nd).

?? Virbac Spain: positions itself as an "excellent place to work" by obtaining Great Place to Work certification. The company has achieved Great Place to Work? certification with a global satisfaction score of 93%. This implies that the company is 25 points above the average of similar companies, as well as 3 points above the average of "Best Place to Work" in Spain. Likewise, within the Virbac group, 14 subsidiaries have been certified. (diarioveterinario.com , April 3th).

?? Richmond Vet Pharma agreed Juvenia Dogs' exclusive distribution: The veterinary laboratory incorporates into its product line the first dietary supplement based on Resveratrol for use in animals. The agreement applies to the entire Argentine territory and aims to leverage the innovative technology used worldwide in the development by Microsules Argentina, further enhancing it with all the commercial and promotional structures that Richmond Vet Pharma has been building and professionalizing in recent years. (motivar.com.ar , April).

?? Elanco US: As part of “Defend Puppies¨ the Defeat Parvo campaign, PAWS Chicago is helping save the lives of puppies sick with canine parvovirus. PAWS Chicago is a founding member of the Parvo Defenders Task Force- a group of advocates educating about parvo, how it spreads, key symptoms, and raising awareness about this deadly disease. PAWS Chicago has saved more than 20 dogs from unnecessarily dying from Parvo with our latest innovative treatment helping meet pet’s unmet needs. (Company LinkedIn. April).

?? Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors extending into 14 members. Ms. Turner brings significant global experience in both the animal health and broader healthcare industries. She has held senior leadership positions at IDEXX Laboratories, including most recently as Chief Marketing Officer, and served in various roles of increasing responsibility at Abbott Laboratories. Mr. Wallace is a well-respected animal health leader with more than 30 years of executive experience at companies such as Fort Dodge Animal Health, Trupanion and Ceva. (prnewswire.com , April 1rst).

?? EU??ECO Animal Health Group?PLC announced that it has sold its ECOmectin Horsepaste product to the Italian firm?ACME Drugs?SRL. for total consideration of EUR 1.3 million ($1.7 million).?(marketscreener ).

?? Merck Animal Health?announced it has received license approval from the USDA for Sequivity with Microsol Diluvac Forte (MDF) adjuvant prescription vaccine for use in gilts and sows. The Sequivity vaccine prescription platform creates custom products for influenza, rotavirus, PCV3, sapovirus and more.?(swineweb ).

?? MSD Animal Health will donate Nobivac? rabies vaccines to the Mission Rabies program, a charitable initiative of the Worldwide Veterinary Service. The donations will be made over the next 5 years, meeting all annual rabies vaccination requirements of this nonprofit organization. (diarioveterinario.com , April).

?? FRANCE? France has selected?Boehringer Ingelheim?and?Ceva Animal Health?to supply a second round of avian influenza vaccines as part of a vaccination campaign that started in autumn last year.? Deliveries are due to begin in April.?(Economic Times ).

?? The European Commission announced a formal investigation into?Zoetis?to probe whether the company violated the region’s antitrust rules by terminating a rival to its dog pain therapy Librela. According to regulators, while developing Librela, Zoetis acquired another late-stage pipeline targeting the same indication; then subsequently terminated its development and refused to transfer its rights to a third party with exclusive regional commercial rights for the product. The investigation was initiated following a complaint from?Virbac. Zoetis has responded that it believes that both the acquisition of the compound and the subsequent decision to cease development of it were sound, rigorous, and lawful.?(seekingalpha ).

?? Zoetis Inc. (NYSE: ZTS) announced on April 1rst the appointment of Gavin D.K. Hattersley, President, Chief Executive Officer, and Director of Molson Coors Beverage Company, to its Board of Directors. Mr. Hattersley brings global public company leadership and board experience, including as a current Chief Executive Officer and former Chief Financial Officer of Molson Coors, to the Zoetis Board. He will serve on the Board’s Corporate Governance and Sustainability Committee. (news.zoetis.com , April).

?? Aquatreck Animal Health has appointed Juan Carlos Castillejo to its Board of Directors. The aquaculture pharmaceutical company, established in Galicia by CZVaccines, has welcomed Juan Carlos Castillejo to its Board of Directors to support the fish vaccine company in implementing its growth strategy. Castillejo brings extensive professional experience in senior management roles within animal health bio-pharmaceutical companies. He holds a degree in Biological Sciences from the Autonomous University of Madrid, a degree in Veterinary Medicine from the Complutense University of Madrid, and a Master's in Business Administration from the Instituto de Empresa. (animalshealth.es , April 6th).

?? Merck Animal Health?announced it has entered into an agreement with?Cambridge Technologies?to sell and market its innovative autogenous poultry vaccines in the US. Cambridge Technologies vaccines are formulated and produced at its USDA-licensed, 37,000-square-foot manufacturing facility featuring state-of-the-art fermentation suites.?(company press release).

?? Panvet XXVII the 2024 edition (Panamerican Congress of Veterinary Sciences), will be held in Uruguay gathering all the Veterinary body of Latin America the 3,4,5, and 6th of December. Detailed information will be disclosed in future editions of this newsletter.

?? Ankyra Therapeutics?and?Jenga Biosciences?announced an exclusive license agreement to develop and commercialize JEN-101 (formerly known as cANK-101), a pre-clinical immuno-oncology agent based on Ankyra’s anchored platform. JEN-101 comprises a fully canine interleukin-12 (IL-12) complexed with aluminum hydroxide; the company has completed an exploratory study of JEN-101 in dogs with advanced melanoma.?(Yahoo finance ).

?? Vivatis Pharma, the German manufacturer of pharmaceutical and nutraceutical products has developed the world's first plant-based hyaluronic acid (although fungi do not strictly belong to the plant kingdom) obtained through extraction rather than fermentation. The acid is extracted from a fungus, Tremella fuciformis, which exhibits properties (high molecular weight) similar to hyaluronic acid found in the human body. Greeniuronic, the name of the new ingredient, was presented at the Nutraceuticals Europe fair on March 6-7 in Barcelona. Its results, published in the International Journal of Molecular Sciences, conclude that it prevents skin aging, helps combat free radicals, promotes wound healing, and increases collagen production. (Company site, April 2nd).

?? Telomir Pharmaceuticals, Inc., announced that Telomir and?Argenta?have agreed to begin a three to six-months study on the efficacy of Telomir-1, a novel small molecule that lengthens the DNA’s protective telomere caps, as a treatment for osteoarthritis and other diseases of aging in canines. (biospace.com ).

Please, follow ?? BERNARDO OTERO and NEXUS ANIMAL HEALTH

Leadership in ANIMAL HEALTH Latin America.

www.animalhealthnexus.com

?

?